Overview

Clinical Study Protocol of Maintenance Therapy With Venetoclax in Elderly Patients With AML in First Complete Remission

Status:
Recruiting
Trial end date:
2028-05-30
Target enrollment:
Participant gender:
Summary
This clinical study evaluates the efficacy and safety of maintenance therapy with BCL-2 inhibitors in elderly patients with acute myeloid leukemia (AML) in first complete remission. This study involves the following content: BCL-2 inhibitors.
Phase:
N/A
Details
Lead Sponsor:
The First Affiliated Hospital with Nanjing Medical University
Collaborators:
Huai'an First People's Hospital
Yancheng First People's Hospital
Treatments:
Anti-Bacterial Agents
Antiemetics
Lenograstim
Venetoclax